In This Issue

Early this fall AIDS activists and the medical community were shocked when Turning Pharmaceuticals raised the price of Daraprim (pyrimethamine), a prescription drug used by many PLWHA who have toxoplasmosis, to $750 a tablet, overnight. Here, Tamara Holmes reports on the positive outcome as a result of the public outcry when these communities mobilized.

As California launches its third open-enrollment period in the health insurance marketplace, it still faces major challenges in enrolling African-Americans and Latinos. We run a piece from Kaiser Health News on the state's plans to reach out to these residents.

A disproportionate number of people with hep C are currently or previously have been incarcerated. The National Hepatitis Corrections Network (NHCN) is introducing a new resource to help educate inmates about hep C. And HRSA has presented findings from a demonstration project to help PLWHA access and complete hep C treatment. AIDS.gov reports.

Finally, the recent #AssaultAtSpringValley reminds us that Black girls' lives matter and that they, too, are being criminalized throughout American society, and particularly in America's schools. Our friends at Colorlines explore the role police play in educational instiutions, what a discipline program should look like and how we can make our schools safer for girls of color.

Yours in the struggle,

Phill